Your browser doesn't support javascript.
loading
The landscape of d16HER2 splice variant expression across HER2-positive cancers.
Volpi, Chiara Costanza; Pietrantonio, Filippo; Gloghini, Annunziata; Fucà, Giovanni; Giordano, Silvia; Corso, Simona; Pruneri, Giancarlo; Antista, Maria; Cremolini, Chiara; Fasano, Elena; Saggio, Serena; Faraci, Simona; Di Bartolomeo, Maria; de Braud, Filippo; Di Nicola, Massimo; Tagliabue, Elda; Pupa, Serenella Maria; Castagnoli, Lorenzo.
Afiliación
  • Volpi CC; Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pietrantonio F; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gloghini A; Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy.
  • Fucà G; Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Giordano S; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Corso S; Department of Oncology, University of Turin, Turin, Italy.
  • Pruneri G; Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy.
  • Antista M; Department of Oncology, University of Turin, Turin, Italy.
  • Cremolini C; Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy.
  • Fasano E; Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Saggio S; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Faraci S; Unit of Medical Oncology, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.
  • Di Bartolomeo M; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • de Braud F; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Di Nicola M; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tagliabue E; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pupa SM; Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Castagnoli L; Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy.
Sci Rep ; 9(1): 3545, 2019 03 05.
Article en En | MEDLINE | ID: mdl-30837627
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Exones / Receptor ErbB-2 Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Exones / Receptor ErbB-2 Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido